3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Genitourinary
1
Conditions
Prostatic Neoplasms
14
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Multiple Myeloma
2
Lymphoma
2
Hematologic Neoplasms
2
Carcinoma, Renal Cell
2
Breast Neoplasms
2
Wilms Tumor
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Thrombocytosis
1
Testicular Neoplasms
1
Testicular Germ Cell Tumor
1
Teratoma
1
Stomach Neoplasms
1
Spinal Cord Neoplasms
1
Sarcoma
1
Rhabdoid Tumor
1
Recurrence
1
Rectal Neoplasms
1
Prostate Cancer Recurrent
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Ovarian Germ Cell Cancer
1
Osteosarcoma
1
Optic Nerve Glioma
1
Oligodendroglioma
1
Interventions
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
2
testosterone undecanoate
1
tempol
1
TEMPOL-H
1
Sirolimus
1
Nelfinavir
1
Metformin
1
Hydroxychloroquine
1
Gonadotropins
1
Diet, Protein-Restricted
1
Dasatinib
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Prostate Cancer Recurrent
×
Dasatinib
×
Genitourinary
×
Clear all
NCT05036226
2026-05-13
COAST
Medical University of South Carolina
Phase 1/2
Recruiting
76 enrolled